A recombinant protein with cancer suppression action, its encoding gene and use

Details for Australian Patent Application No. 2003280921 (hide)

International Classifications

Event Publications

4 March 2004 Complete Application Filed

7 July 2005 Application Open to Public Inspection

Published as AU-B-2003280921

8 March 2007 Assignment before Grant

Beijing Sunbio Biotech Co., Ltd The application has been assigned to Sun Biotech Pharmaceuticals (Tianjin) Co. Ltd.

26 April 2007 Change of Name(s) of Applicant(s), Section 104

Sun Biotech Pharmaceuticals (Tianjin) Co. Ltd. The name of the applicant has been changed to Sunbio Biotech Pharmaceuticals (Tianjin) Co. Ltd. 2004

13 September 2007 Application Accepted

Published as AU-B-2003280921

17 January 2008 Standard Patent Sealed

23 September 2010 Assignment Registered

Sunbio Biotech Pharmaceuticals (Tianjin) Co. Ltd. The patent has been assigned to Beijing Sunbio Biotech Co., Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.